bisbenzimidazole has been researched along with Anterior Horn Cell Disease in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigini, P | 1 |
| Veglianese, P | 1 |
| Andriolo, G | 1 |
| Cova, L | 1 |
| Grignaschi, G | 1 |
| Caron, I | 1 |
| Daleno, C | 1 |
| Barbera, S | 1 |
| Ottolina, A | 1 |
| Calzarossa, C | 1 |
| Lazzari, L | 1 |
| Mennini, T | 1 |
| Bendotti, C | 1 |
| Silani, V | 1 |
1 other study available for bisbenzimidazole and Anterior Horn Cell Disease
| Article | Year |
|---|---|
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration.
Topics: Amyotrophic Lateral Sclerosis; Animals; Bisbenzimidazole; Cell- and Tissue-Based Therapy; Cytokines; | 2011 |